ALS drug trial halted before results
NCT ID NCT03757351
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 27 times
Summary
This early-phase study tested the safety of an experimental drug called DNL747 in 15 people with ALS. The trial was stopped early, so we don't know if the drug helps control the disease or ease symptoms. The main goal was to check for side effects, not to measure any treatment benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bioclinica
Orlando, Florida, 32806, United States
-
CHDR
Leiden, South Holland, 2333, Netherlands
-
PRA Health Sciences
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.